Abstract
Main conclusion
LSC CO17-1AK and anti-HER2 VHH-FcK can be produced in a single plant and exhibit anti-tumor activities comparable to those of their respective parent antibodies.
Abstract
Recombinant monoclonal antibodies (mAbs) which can be applied to treat various cancers, are primarily produced using mammalian, insect, and bacteria cell culture systems. Plant expression systems have also been developed to produce antibodies. Plant expression systems present several advantages, including a lack of human pathogenic agents, efficient production costs, and easy large-scale production. In this study, we generated a transgenic plant expressing anti-colorectal cancer large single chain (LSC) CO17-1AK and anti-human epidermal growth factor receptor 2 (HER2) VHH-FcK mAbs by cross-pollinating plants expressing LSC CO17-1AK and anti-HER2 VHH-FcK, respectively. F1 siblings expressing both LSC CO17-1AK and anti-HER2 VHH-FcK were screened using polymerase chain reaction and Western-blot analyses. The cell enzyme-linked immunosorbent assay (Cell ELISA) confirmed the binding of LSC CO17-1AK and anti-HER2 VHH-FcK to target proteins in the SW620 human colorectal cancer and the SKBR-3 human breast cancer cell lines, respectively. The wound healing assay confirmed the inhibitory activity of both antibodies against SW620 and SKBR-3 cell migration, respectively. In conclusion, both LSC CO17-1AK mAb and anti-HER2 VHH-FcK can be produced in a single plant, achieve binding activities to SW620 and SKBR-3 cancer cells, and inhibitory activity against SW620 and SKBR-3 cell migration similar to their parental antibodies, respectively.
Similar content being viewed by others
Data availability
The datasets generated during and/or analyzed during the current study are available from the corresponding author on reasonable request.
Abbreviations
- CRC:
-
Colorectal cancer
- HC:
-
IgG heavy chain
- HER2:
-
Human epidermal growth factor receptor 2
- LC:
-
IgG light chain
- LSC:
-
Large single chain
- mAb:
-
Monoclonal antibody
References
Ayan A, Meriç S, Gümüş T, Atak Ç (2022) Next generation of transgenic plants: from farming to pharming. Genetically modified plants and beyond. IntechOpen. https://doi.org/10.5772/intechopen.102004
Bathula NV, Bommadevara H, Hayes JM (2021) Nanobodies: the future of antibody-based immune therapeutics. Cancer Biother Radiopharm 36(2):109–122
Brodzik R, Spitsin S, Golovkin M, Bandurska K, Portocarrero C, Okulicz M, Steplewski Z, Koprowski H (2008) Plant-derived EpCAM antigen induces protective anti-cancer response. Cancer Immunol Immunother 57:317–323
Buyel JF, Twyman RM, Fischer R (2017) Very-large-scale production of antibodies in plants: the biologization of manufacturing. Biotechnol Adv 35(4):458–465
Ferrando-Díez A, Felip E, Pous A, Bergamino Sirven M, Margelí M (2022) Targeted therapeutic options and future perspectives for HER2-positive breast cancer. Cancers 14(14):3305
Gong D, Riley TP, Bzymek KP, Correia AR, Li D, Spahr C, Robinson JH, Case RB, Wang Z, Garces F (2021) Rational selection of building blocks for the assembly of bispecific antibodies. Mabs 13(1):1870058
Harmsen MM, De Haard HJ (2007) Properties, production, and applications of camelid single-domain antibody fragments. Appl Microbiol Biotechnol 77(1):13–22
Jamal A, Lee J-H, Lee K-J, Oh D-B, Kim D-S, Lee K-K, Choo Y-K, Hwang K-A, Ko K (2012) Chimerism of multiple monoclonal antibodies expressed in a single plant. Hortic Environ Biotechnol 53:544–551
Kim K, Kang YJ, Park SR, Kim DS, Lee SW, Ko K, Ponndorf D, Ko K (2021) Effect of leaf position and days post-infiltration on transient expression of colorectal cancer vaccine candidate proteins GA733-Fc and GA733-FcK in Nicotiana benthamiana plant. PeerJ 9:e10851
Le Du F, Dièras V, Curigliano G (2021) Corrigendum to ‘the role of tyrosine kinase inhibitors in the treatment of HER2+ metastatic breast cancer’[European Journal of Cancer 154 (2021) 175–189]. Eur J Cancer 158:255
Lee JH, Ko K (2017) Production of recombinant anti-cancer vaccines in plants. Biomol Ther (seoul) 25(4):345–353
Lee JH, Park SR, Phoolcharoen W, Ko K (2020) Expression, function, and glycosylation of anti-colorectal cancer large single-chain antibody (LSC) in plant. Plant Biotechnol Rep 14:363–371
Lim S, Kim D-S, Ko K (2020) Expression of a large single-chain 13F6 antibody with binding activity against Ebola virus-like particles in a plant system. Int J Mol Sci 21(19):7007
Lim C-Y, Kim D-S, Kang Y, Lee Y-R, Kim K, Kim M-S, Ko K (2022) Immune responses to plant-derived recombinant colorectal cancer glycoprotein EpCAM-FcK fusion protein in mice. Biomol Ther (seoul) 30(6):546–552
Loh H-S (2014) Optimizations of laboratory-scale vacuum-assisted agroinfiltration for delivery of a transgene in Nicotiana benthamiana. Asian J Biotechnol 6:25–37. https://doi.org/10.3923/ajbkr.2014
Loibl S, Gianni L (2017) HER2-positive breast cancer. Lancet 389(10087):2415–2429
Lomonossoff GP, D’Aoust M-A (2016) Plant-produced biopharmaceuticals: a case of technical developments driving clinical deployment. Science 353(6305):1237–1240
Mamaloudis I, Zacharoulis D, Samara M, Papadopoulos G, Samara S, Koukoulis G, Chatzitheofilou C, Kollia P (2015) Expression profile of the GA733 gene family in colorectal cancer: correlation with clinicopathological parameters. Genet Mol Res 14(4):14772–14781
Mayfield SP, Franklin SE, Lerner RA (2003) Expression and assembly of a fully active antibody in algae. Proc Natl Acad Sci USA 100(2):438–442
Moussavou G, Ko K, Lee J-H, Choo Y-K (2015) Production of monoclonal antibodies in plants for cancer immunotherapy. BioMed Res Int 2015:306164
Nessa MU, Rahman MA, Kabir Y (2020) Plant-produced monoclonal antibody as immunotherapy for cancer. BioMed Res Int 2020:3038564
Park SR, Lee J-H, Kim K, Kim TM, Lee SH, Choo Y-K, Kim KS, Ko K (2020) Expression and in vitro function of anti-breast cancer llama-based single domain antibody VHH expressed in tobacco plants. Int J Mol Sci 21(4):1354
Park SH, Ji K-Y, Park SY, Kim HM, Ma SH, Do JH, Kang H, Kang HS, Oh D-B, Shim JS (2022) Immunotherapeutic effects of recombinant colorectal cancer antigen produced in tomato fruits. Sci Rep 12(1):9723
Sack M, Hofbauer A, Fischer R, Stoger E (2015) The increasing value of plant-made proteins. Curr Opin Biotechnol 32:163–170
Shin C, Kang Y, Kim H-S, Shin YK, Ko K (2019) Immune response of heterologous recombinant antigenic protein of viral hemorrhagic septicemia virus (VHSV) in mice. Anim Cells Syst (seoul) 23(2):97–105
Shin C, Kim K, Kang YJ, Kim D-S, Seo Y-J, Park SR, Kim MK, Lee YK, Kim D-S, Ko K (2022) Effect of IgG Fc-fusion and KDEL-ER retention signal on prostate-specific antigen expression in plant and its immune in mice. Plant Biotechnol Rep 16(6):729–740
Siegel RL, Miller KD, Goding Sauer A, Fedewa SA, Butterly LF, Anderson JC, Cercek A, Smith RA, Jemal A (2020) Colorectal cancer statistics. CA Cancer J Clin 70(3):145–164
Sitia L, Sevieri M, Signati L, Bonizzi A, Chesi A, Mainini F, Corsi F, Mazzucchelli S (2022) HER-2-targeted nanoparticles for breast cancer diagnosis and treatment. Cancers 14(10):2424
Slamon DJ, Clark GM, Wong SG, Levin WJ, Ullrich A, McGuire WL (1987) Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science 235(4785):177–182
Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F (2021) Global cancer statistics 2020: globocan estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 71(3):209–249
Vasconcellos FA, Aleixo PB, Stone SC, Conceição FR, Dellagostin OA, Aleixo JAG (2013) Generation and characterization of new HER2 monoclonal antibodies. Acta Histochem 115(3):240–244
Yarden Y, Sliwkowski MX (2001) Untangling the ErbB signalling network. Nat Rev Mol Cell Biol 2(2):127–137
Yu D (2001) Mechanisms of ErbB2-mediated paclitaxel resistance and trastuzumab-mediated paclitaxel sensitization in ErbB2-overexpressing breast cancers. Semin Oncol 28(5 Suppl 16):12–17
Acknowledgements
This research was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIT) [2021R1F1A1063869].
Author information
Authors and Affiliations
Contributions
Conceptualization: CJ, and KK; Methodology: CJ, and YJK; Formal analysis and investigation: CJ, SRP, and YJO; Resources: SRP, and KK; Writing—original draft preparation: CJ; Writing—review and editing: CJ, and KK; Supervision: KK.
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Additional information
Communicated by Dorothea Bartels.
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Jin, C., Kang, Y.J., Park, S.R. et al. Production, expression, and function of dual-specific monoclonal antibodies in a single plant. Planta 259, 15 (2024). https://doi.org/10.1007/s00425-023-04284-z
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s00425-023-04284-z